BREO ELLIPTA
BREO ELLIPTA
Approved
DIN Number
02444186
Drug Class
Human
Market Date
Oct 2, 2015
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02444186
AIG Number0254450004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AK10 VILANTEROL AND FLUTICASONE FUROATE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
FLUTICASONE FUROATEActive
Strength: 200 MCG / ACT
Monograph: FLUTICASONE FUROATE
VILANTEROL (VILANTEROL TRIFENATATE)Active
Strength: 25 MCG / ACT
Monograph: VILANTEROL (VILANTEROL TRIFENATATE)